Pneumocystis jirovecii Colonization in Preterm Newborns With Respiratory Distress Syndrome

Magdalena Szydłowicz1, Barbara Królak-Olejnik2, Sergio L Vargas3

  • 1Department of Biology and Medical Parasitology, Wroclaw Medical University, Wroclaw, Poland.

Insights

Pneumocystis jirovecii was detected in newborns and mothers, suggesting possible transmission before birth. Infant colonization was linked to bronchopulmonary dysplasia, highlighting its clinical importance.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Pneumocystis jirovecii is an opportunistic pathogen.
  • Very low birth weight (VLBW) newborns (<32 weeks gestation) are highly susceptible to infections.
  • The prevalence and transmission routes of P. jirovecii in VLBW infants are not well understood.

Purpose of the Study:

  • To determine the prevalence of P. jirovecii in mother-infant pairs of VLBW newborns.
  • To investigate potential transmission routes, including transplacental transmission.
  • To assess the clinical significance of P. jirovecii colonization in VLBW infants.

Main Methods:

  • Molecular and microscopic methods were employed for pathogen detection.
  • Specimens were collected from nasopharyngeal aspirates of newborns and oral washes of mothers.
  • A total of 56 newborns and 34 mothers were included in the study.

Main Results:

  • Pneumocystis DNA was detected in 14% of newborn nasopharyngeal aspirates (8/56).
  • Pneumocystis DNA was detected in 21% of maternal oral washes (7/34).
  • Infants colonized with P. jirovecii showed a higher incidence of bronchopulmonary dysplasia (P=0.02) compared to non-colonized infants.

Conclusions:

  • P. jirovecii detection shortly after birth suggests potential transplacental transmission.
  • P. jirovecii colonization may play a role in abnormal lung development in VLBW infants.
  • Early detection and management strategies for P. jirovecii in VLBW infants may be warranted.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
463
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
557
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
553
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
613